Open this publication in new window or tab >>Show others...
2020 (English)In: Science of the Total Environment, ISSN 0048-9697, E-ISSN 1879-1026, Vol. 703, article id 134701Article in journal (Refereed) Published
Abstract [en]
Pollution by psychoactive pharmaceuticals has been found to disrupt anti-predator behaviors of wild fish. The challenge is now to identify which of the many psychoactive drugs pose the greatest threat. One strategy is to screen for behavioral effects of selected pharmaceuticals using a single, widely available fish species such as zebrafish. Here, we show that although such high-throughput behavioral screening might facilitate comparisons between pharmaceuticals, the choice of strain is essential. While wild-caught zebrafish exposed to concentrations of the anxiolytic drug oxazepam as low as 0.57 μg L−1 showed a reduction in the response to conspecific alarm pheromone, laboratory strain AB did not respond to the alarm cue, and consequently, the anxiolytic effect of oxazepam could not be measured. Adaptation to the laboratory environment may have rendered laboratory strains unfit for use in some ecotoxicological and pharmacological studies, since the results might not translate to wild fish populations.
Place, publisher, year, edition, pages
Elsevier, 2020
National Category
Behavioral Sciences Biology
Identifiers
urn:nbn:se:uu:diva-395990 (URN)10.1016/j.scitotenv.2019.134701 (DOI)000505924300102 ()31734507 (PubMedID)
Funder
Swedish Research Council, 2012-04679Swedish Research Council, 2017-03779The Kempe FoundationsThe Research Council of Norway, 62942Swedish Research Council Formas, 2013-4431
2019-10-282019-10-282021-11-02Bibliographically approved